<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Artime</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Qizilbash</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Garrido-Estepa</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Vora</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Soriano-Gabarr√≥</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Asiimwe</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Are risk minimization measures for approved drugs in Europe effective? A systematic review</article-title>
  <source>Expert Opin Drug Saf</source>
  <year>2019</year>
  <volume>18</volume>
  <issue>5</issue>
  <fpage>443</fpage>
  <lpage>454</lpage>
  <pub-id pub-id-type="doi">10.1080/14740338.2019.1612875</pub-id>
  <pub-id pub-id-type="pmid">31032651</pub-id>
 </element-citation>
</ref>
